Comparing Perclose to Statseal in Conjunction With Perclose in Femoral 6 French Arteriotomy Closure
Status:
Not yet recruiting
Trial end date:
2023-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this clinical study is to compare how well two different devices for achieving
hemostasis perform in patients undergoing transfemoral procedures with 6 French Access. Both
devices are approved by the FDA for this use, and have already been used by clinicians on
patients undergoing transfemoral procedures. It is believed that the use of both devices in
combination compared to the Perclose alone will shorten the time that it takes to 'seal' the
artery, resulting in a shorter period of time that patients would need to lay flat.